Navigation Links
Scios Inc. targets drug giants in arthritis war

Scios Inc. , a small California biotechnology company, is racing giant rivals to bring a pill to market that would displace injectable anti-inflammatory drugs and set a new standard in arthritis treatment. Scios' ambitions are much larger than its market capitalization of a little more than $1 billion. That's because the first company to commercialize an oral version of today's dominant injectable drugs could gain the lion's share of a market. //

Scios' drug has shown promise in early trials. But the size of the potential market makes it a prize that many big pharmaceuticals companies also covet. So far, Scios' prospects look good. The company's pill appears to inhibit an enzyme, known as the p38 kinase, which provokes inflammation.

Scios' lead comes in part because an earlier trailblazer, Vertex Pharmaceuticals Inc. , was forced to drop back after its lead p38 kinase inhibitor showed toxicity in high doses in some animals. There are also many competitors. They include drug giant GlaxoSmithKline, which first isolated the p38 kinase in the early 1990s. Glaxo's drug is in early stage clinical trials for rheumatoid arthritis, asthma and irritable bowel syndrome. Other rivals include Merck and Co. Inc. , Roche Holding Ltd. , Johnson and Johnson, and Amgen Inc.

Scion Inc. has completed trials in healthy humans and is now planning to test the drug in patients with rheumatoid arthritis. Most rivals have yet to reach this stage.
'"/>




Page: 1

Related medicine news :

1. South Africa Wins landmark case against pharmaceutical giants
2. Vedic vibration technology- the new cure for arthritis
3. Tai chi helps arthritis
4. Periodontitis a common problem in patients with arthritis
5. New device for discerning Osteoarthritis
6. Herbal extract aids in rheumatoid arthritis
7. Osteoarthritis and Estrogen are connected
8. Hyaluronan supplementation therapy for Knee Osteoarthritis
9. Green tea beneficial in preventing osteoarthritis
10. Leech Therapy for Osteoarthritis
11. Hydrotherapy Found to be Effective for Patients with Osteoarthritis
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:9/19/2017)... ... September 19, 2017 , ... Spain’s popular line ... Laboratories, is coming soon to RonnieColemanNutrition.com. , ACPG Laboratories has been in ... trusted, well-respected brand reliant on the healing properties of plants, a proven science ...
(Date:9/19/2017)... ... September 19, 2017 , ... ... to serve as strategic adviser to the animal healthcare division of Sonoma ... Bridge Animal Referral Center (BARC) in Edmonds, Washington, which specializes in compassionate ...
(Date:9/19/2017)... ... , ... Premiere Long Island dental office Gold Coast Smiles is pleased to ... dentists in America under age 40 by Incisal Edge magazine. , Incisal Edge ... the best 40 dentists under the age of 40 renowned for medical innovations and ...
(Date:9/19/2017)... ... September 19, 2017 , ... When it comes to household ... deserve clear instructions on how to keep babies and toddlers safe, and there's no ... Safety Month. , Great Time to Check Labels, Brands that sell all kinds of ...
(Date:9/19/2017)... ... September 19, 2017 , ... Emergency ... the Certified Emergency Nurse (CEN®) certification according to a large-scale study ... of certification study, conducted by the Human Resources Research Organization (HumRRO) in late ...
Breaking Medicine News(10 mins):
(Date:9/6/2017)... TORONTO , Sept. 6, 2017 /PRNewswire/ ... new knowledge and skills while treating their ... for hands-on experience without involving patients. Simulation ... skills. Clinicians can carry out procedures, refine ... at risk. Integration of new technology, such ...
(Date:9/5/2017)... KEYSTONE, Colo. , Sept. 5, 2017 ... their XR-29 DoseCheck solution. Scannerside DoseCheck is a third-party ... update existing CT scanners and allows compliance with current ... The Sapheneia-Scannerside proprietary XR 29 DoseCheck solution is specifically ... notifications and alerts of potential radiation doses over a ...
(Date:9/5/2017)... Oramed Pharmaceuticals Inc. (NASDAQ: ORMP ... company focused on the development of oral drug delivery ... meeting with the U.S. Food and Drug Administration (FDA) ... At the meeting, the ... submission of ORMD-0801, would be a Biologics License Application ...
Breaking Medicine Technology: